Wilson Sonsini Goodrich & Rosati and Fenwick & West advised DiCE Molecules on the deal. DiCE Molecules, a biopharmaceutical company leveraging its proprietary DNA-encoded library platform…
DiCE Molecules’ $60 Million Series C-1 Financing


Wilson Sonsini Goodrich & Rosati and Fenwick & West advised DiCE Molecules on the deal. DiCE Molecules, a biopharmaceutical company leveraging its proprietary DNA-encoded library platform…
…